35%

  1. E

    May not see 35% growth in H1 sustaining in H2

    Glenn Saldanha, MD & CEO, Glenmark said the pharma major is growth at the rate of 30% in the Indian market and is confident of maintaining margins ahead. The drug maker clocked a net profit of Rs 156 crore for the second quarter ended September 30 compared with Rs 56 crore registered in the...
  2. R

    Inflation rises to 3.5%

    Inflation rose to 3.50 per cent for the week ended December 22, compared to 3.45 per cent in the previous week, mainly due to increase in prices of some manufactured and fuel items. The wholesale price-based inflation stood at 5.78 per cent in the corresponding week a year ago. Among...
Back
Top